BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23139293)

  • 1. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
    Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Acyl-CoA:Cholesterol Acyltransferase Inhibition, Combined with Apoprotein A1 Overexpression, Promotes Atherosclerosis Inflammation Resolution in Mice.
    Amengual J; Ogando Y; Nikain C; Quezada A; Qian K; Vaisar T; Fisher EA
    Mol Pharmacol; 2021 Mar; 99(3):175-183. PubMed ID: 33384285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice.
    Kusunoki J; Hansoty DK; Aragane K; Fallon JT; Badimon JJ; Fisher EA
    Circulation; 2001 May; 103(21):2604-9. PubMed ID: 11382731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
    Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
    Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
    Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice.
    Lenglet S; Thomas A; Soehnlein O; Montecucco F; Burger F; Pelli G; Galan K; Cravatt B; Staub C; Steffens S
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):215-23. PubMed ID: 23241405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
    Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.
    Wen G; An W; Chen J; Maguire EM; Chen Q; Yang F; Pearce SWA; Kyriakides M; Zhang L; Ye S; Nourshargh S; Xiao Q
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE
    Zhang M; Zeng X; Yang Q; Xu J; Liu Z; Zhou Y; Cao Y; Zhang X; An X; Xu Y; Huang L; Han Z; Wang T; Wu C; Fulton DJ; Weintraub NL; Hong M; Huo Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2780-2792. PubMed ID: 30571174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
    Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
    Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
    Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
    Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.
    Li G; Wu XW; Lu WH; Ai R; Chen F; Tang ZZ
    BMC Cardiovasc Disord; 2014 Oct; 14():145. PubMed ID: 25326709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.